From https://www.rxlist.com/dupixent-drug.htm
"Dupilumab is produced by recombinant DNA technology in Chinese Hamster Ovary cell suspension culture."
Administering Dupilumab appears a tad complicated:
"DUPIXENT is administered by subcutaneous injection."
"During the 52-week treatment period of concomitant therapy trial (Trial 3), conjunctivitis was reported in 16% of the DUPIXENT 300 mg Q2W + TCS group (20 per 100 subject-years) and in 9% of the placebo + TCS group (10 per 100 subject-years) [see WARNINGS AND PRECAUTIONS]."
So IMO results so far suggest BTX 1204 will be generally superior to DUPIXENT.
DYOR, I am not a doctor although I am currently attending my grand-children's sick cat, assisted by a doctor.
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-115
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.020(5.97%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 36.0¢ | 33.3¢ | $2.622M | 7.530M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 106888 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 462320 | 5 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
